Alpha Tau Medical Ltd.

NasdaqCM:DRTS Stock Report

Market Cap: US$173.5m

Alpha Tau Medical Management

Management criteria checks 4/4

Alpha Tau Medical's CEO is Uzi Sofer, appointed in Jan 2015, has a tenure of 9.33 years. total yearly compensation is $630.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 16.53% of the company’s shares, worth $28.67M. The average tenure of the management team and the board of directors is 5.3 years and 7.3 years respectively.

Key information

Uzi Sofer

Chief executive officer

US$630.0k

Total compensation

CEO salary percentage100.0%
CEO tenure9.3yrs
CEO ownership16.5%
Management average tenure5.3yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Nov 08
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Alpha Tau director gives up board seat to take up chief commercial officer role

Sep 02

Alpha Tau Medical GAAP EPS of -$0.03

Aug 25

Alpha Tau: Treating Cancer With Precision Alpha Radiation

Apr 12

CEO Compensation Analysis

How has Uzi Sofer's remuneration changed compared to Alpha Tau Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$630kUS$630k

-US$29m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$16m

Dec 31 2022US$3mUS$628k

-US$34m

Compensation vs Market: Uzi's total compensation ($USD630.00K) is below average for companies of similar size in the US market ($USD1.64M).

Compensation vs Earnings: Uzi's compensation has been consistent with company performance over the past year.


CEO

Uzi Sofer (53 yo)

9.3yrs

Tenure

US$630,000

Compensation

Mr. Uzi Sofer serves as Chief Executive Officer and Chairman at Alpha Tau Medical LTD (Alternate name Healthcare Capital Corp.) since 2015. He founded Brainsway Ltd., in 2006 and served as its Chief Execut...


Leadership Team

NamePositionTenureCompensationOwnership
Uzi Sofer
CEO & Chairman9.3yrsUS$630.00k16.53%
$ 28.7m
Raphi Levy
Chief Financial Officer5.3yrsUS$424.00k0%
$ 0
Amnon Gat
Chief Operations Officer6.3yrsUS$340.00k0.098%
$ 170.5k
Peter Melnyk
Chief Commercial Officer1.7yrsUS$376.00k0%
$ 0
Robert Den
Chief Medical Officer & Member of Scientific Advisory Board4.7yrsUS$401.00k0%
$ 0
Ronen Segal
Chief Technology Officer5.3yrsUS$705.00k0%
$ 0
Yona Keisari
Chief Scientific Officer & Member of Scientific Advisory board4.7yrsno data0.72%
$ 1.3m
Rebecca Becker
Vice President of legalno datano datano data
Itzhak Kelson
Chief Physics Officer & Member of Scientific Advisory Board8.3yrsno data1.91%
$ 3.3m
Yael Zeiger
Corporate Controllerno datano datano data

5.3yrs

Average Tenure

50yo

Average Age

Experienced Management: DRTS's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Uzi Sofer
CEO & Chairman9.3yrsUS$630.00k16.53%
$ 28.7m
Robert Den
Chief Medical Officer & Member of Scientific Advisory Boardno dataUS$401.00k0%
$ 0
Yona Keisari
Chief Scientific Officer & Member of Scientific Advisory board4.7yrsno data0.72%
$ 1.3m
Itzhak Kelson
Chief Physics Officer & Member of Scientific Advisory Boardno datano data1.91%
$ 3.3m
Ruth Alon
Independent Director2.2yrsno data0%
$ 0
Alan Adler
Independent Director6.3yrsno data0%
$ 0
David Milch
Independent Director2.2yrsno data0.13%
$ 226.0k
Meir Jakobsohn
Independent Director8.3yrsno data0.38%
$ 662.0k
Michael Zelefsky
Member of Scientific Advisory Boardno datano datano data
S. Blumenfeld
Independent Director8.3yrsno data0.068%
$ 117.2k
Michael Avruch
Director8.3yrsno data2.22%
$ 3.9m
Aron Popovtzer
Member of Scientific Advisory Boardno datano datano data

7.3yrs

Average Tenure

69yo

Average Age

Experienced Board: DRTS's board of directors are considered experienced (7.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.